More about Zydus Lifesciences Limited
Fundamentals for Zydus Lifesciences Limited
Regulatory Filings for Zydus Lifesciences Limited
IndiGo Implements Steep Fuel Surcharge as Iran Conflict Sends Jet Fuel Costs Soaring
The RBI's New Forex Fortress: Defensive Maneuvers in an Era of Oil Shocks
India's Fiscal Milestone: GST Collections Breach ₹2 Lakh Crore Mark for the First Time
AI Disruption Accelerates: Oracle Layoffs Raise Alarms for India’s Tech Workforce
Technicals for Zydus Lifesciences Limited
Price Summary
Zydus Lifesciences Limited's stock opened at 891.2 on 2026-04-09, surged to 909.9, hit a low of 888.55, and closed up 1.24% at 902.25, with 705253 shares traded.The stock's peak price over the last 52 weeks is 1047.85, with the lowest being 0.0.
Technicals
Support and Resistance: At 902.25, the price is supported at 901.45 and faces resistance at 937.25. This range suggests that the price for ZYDUSLIFE might stay between these levels, with 901.45 acting as a floor and 937.25 as a ceiling.Aroon: The current reading of the AROON indicator suggests a neutral stance, with no clear signals indicating an upward or downward direction. This lack of directional bias suggests the market may be in a period of consolidation or uncertainty.
Bol. Bands: The current state of the BOLL BANDS is neutral for ZYDUSLIFE, providing no clear indication of a trend in either direction. This suggests that the market may be lacking momentum, making it difficult to predict future movements.
Parabolic SAR: The PSAR for ZYDUSLIFE continues to signal a bullish outlook, establishing a crucial support level that may help sustain the current upward momentum. This level of support suggests that the market is likely to continue trending higher, providing a foundation for ongoing bullish movement.
Stochastic: The STOCHASTIC is showing a neutral reading, with no clear direction indicated for upward or downward movement. This neutral position suggests a possible period of consolidation.
Tripple Moving Agerage: The Tripple MOVING AVG is currently in a neutral position for Zydus Lifesciences Limited, offering no clear guidance on whether the market is likely to move up or down. This neutral stance suggests that further observation may be necessary before a trend becomes apparent.
To make the most of a company's technical analysis, it's important to start with an understanding of its fundamentals. These include profitability, cash flow, and competitive positioning. Additionally, the industry in which the company operates plays a critical role, as trends and external factors can influence its market performance. By considering both the company's internal fundamentals and the external industry environment, more meaningful and accurate conclusions can be drawn from the technical data.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
U.S. Labor Market in 2026: JOLTS and Consumer Confidence Reveal Why Hiring Cooled Without Unemployment Spike
Lending Unleashed: Assessing the Impact of the Federal Reserve’s Capital Rollback
Calendar Collision: How Mahavir Jayanti's Overlap With Fiscal Year-End Reshapes India's Tax-Loss Harvesting Landscape